Literature DB >> 15952901

Gene therapy: twenty-first century medicine.

Inder M Verma1, Matthew D Weitzman.   

Abstract

Broadly defined, the concept of gene therapy involves the transfer of genetic material into a cell, tissue, or whole organ, with the goal of curing a disease or at least improving the clinical status of a patient. A key factor in the success of gene therapy is the development of delivery systems that are capable of efficient gene transfer in a variety of tissues, without causing any associated pathogenic effects. Vectors based upon many different viral systems, including retroviruses, lentiviruses, adenoviruses, and adeno-associated viruses, currently offer the best choice for efficient gene delivery. Their performance and pathogenicity has been evaluated in animal models, and encouraging results form the basis for clinical trials to treat genetic disorders and acquired diseases. Despite some initial success in these trials, vector development remains a seminal concern for improved gene therapy technologies.

Entities:  

Mesh:

Year:  2005        PMID: 15952901     DOI: 10.1146/annurev.biochem.74.050304.091637

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  139 in total

Review 1.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

2.  Optimization of magnetic nanoparticle-assisted lentiviral gene transfer.

Authors:  Christina Trueck; Katrin Zimmermann; Olga Mykhaylyk; Martina Anton; Sarah Vosen; Daniela Wenzel; Bernd K Fleischmann; Alexander Pfeifer
Journal:  Pharm Res       Date:  2012-01-25       Impact factor: 4.200

3.  The molecular interaction of CAR and JAML recruits the central cell signal transducer PI3K.

Authors:  Petra Verdino; Deborah A Witherden; Wendy L Havran; Ian A Wilson
Journal:  Science       Date:  2010-09-03       Impact factor: 47.728

4.  20 years of gene therapy for SCID.

Authors:  Alain Fischer; Salima Hacein-Bey-Abina; Marina Cavazzana-Calvo
Journal:  Nat Immunol       Date:  2010-06       Impact factor: 25.606

5.  Recombinant adenovirus-mediated expression of GHS-R1a in HEK 293 cells.

Authors:  Li Liu; Hua-Min Xu; Hong Jiang; Jun Wang; Ning Song; Jun-Xia Xie
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

6.  Gene transfer of c-met confers protection against D-galactosamine/lipopolysaccharide-induced acute liver failure.

Authors:  Chuanlong Zhu; Yuwen Li; Wenting Li; Quan Wu; Rentao Gao
Journal:  Dig Dis Sci       Date:  2012-01-24       Impact factor: 3.199

Review 7.  Artificial and engineered chromosomes: developments and prospects for gene therapy.

Authors:  Brenda R Grimes; Zoia Larin Monaco
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

8.  Near-maximal expansions of hematopoietic stem cells in culture using NUP98-HOX fusions.

Authors:  Hideaki Ohta; Sanja Sekulovic; Silvia Bakovic; Connie J Eaves; Nicolas Pineault; Maura Gasparetto; Clayton Smith; Guy Sauvageau; R Keith Humphries
Journal:  Exp Hematol       Date:  2007-05       Impact factor: 3.084

9.  An electrically active microneedle array for electroporation.

Authors:  Seong-O Choi; Yeu Chun Kim; Jung-Hwan Park; Joshua Hutcheson; Harvinder S Gill; Yong-Kyu Yoon; Mark R Prausnitz; Mark G Allen
Journal:  Biomed Microdevices       Date:  2010-04       Impact factor: 2.838

10.  Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells.

Authors:  Miho Murakami; Hideyo Ugai; Natalya Belousova; Alexander Pereboev; Paul Dent; Paul B Fisher; Maaike Everts; David T Curiel
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.